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INTRODUCTION
Chronic diarrhea is a common diagnostic dilemma faced 
by many internists. First reported by R. Kaijser in 1937, pri-
mary eosinophilic gastroenteritis (PEG) is associated with 
eosinophilic infiltration and degranulation in the digestive 
tract (DT). Presentation is often nonspecific but commonly 
depends on the depth of eosinophilic infiltration in the DT. 
While diagnosis is based on clinical symptoms and a biopsy 
specimen, peripheral eosinophilia is commonly absent. 
Herein, we describe a patient with multiple hospital admis-
sions for diarrhea, who was ultimately diagnosed with PEG.
CASE PRESENTATION
We report the case of a 46-year-old female with no past 
medical history who presented with recurrent hospitaliza-
tions for relapsing remitting abdominal pain and diarrhea 
over nine months. On two prior hospitalizations, no fever 
or eosinophilia was reported, and she received metronida-
zole with a working diagnosis of bacterial gastroenteritis 
(Figure 1A). Five days prior to admission, she had devel-
oped cramping epigastric pains and five to 10 episodes 
of foul-smelling, yellow, nonbloody, watery, mucousy diar-
rhea. Upon her arrival in the emergency room, her vital 
signs were within normal limits. A physical exam revealed 
hyperactive bowel sounds and mild tenderness throughout 
the abdomen. A rectal examination revealed light-brown 
guaiac-negative stool. She had an elevated white blood cell 
count (14,200) with a differential showing elevated eosino-
phils (25%, 2,820; Figure 1A). IgE levels were elevated 
(2130/ul; n = < 180/ul). An abdominal computed tomog-
raphy scan was unremarkable. Infectious labs, including 
Clostridium difficile toxin and stool for ova and parasites 
x3, were negative. Further evaluation revealed a normal 
ANA panel, thyroid function tests, folate and vitamin B12 
levels, and fecal fat and electrolytes. A duodenal biopsy 
specimen demonstrated chronic enteritis with villous short-
ening, crypt hyperplasia, regeneration, and increased stro-
mal mononuclear (eosinophil) inflammation and infiltration 
(Figure 1B). She was diagnosed with PEG. While hospital-
ized, the patient was advised to adhere to an elemental 
diet. Her symptoms improved within one week without 
medication and she was followed up closely as an outpa-
tient. At her one-month follow-up, she reported decreased 
pruritus, drowsiness, and frequency of diarrhea. She was 
able slowly to advance her diet. Her IgE and eosinophil 
levels began to trend down (983 and 600/ul respectively; 
Figure 1A) without therapeutic intervention. Continuous 
monitoring was initiated in the clinic to screen for a relapse 
of symptoms. 
DISCUSSION
Pathogenesis
Eosinophils are created in the bone marrow and, following 
exposure to growth factors, mature and relocate throughout 
the body. They can be found at different levels throughout 
the gastrointestinal system (e.g., 0/high power field [hpf] in 
the esophagus and up to 68/hpf in the appendix) and play 
a protective role, especially in fighting parasitic infections 
(DeBrosse, Case, Putnam, Collins, & Rothenberg, 2006; 
Khan & Orenstein, 2008). Eosinophils are activated by the 
TH2 cellular pathway through proinflammatory stimulant 
cytokines such as IL-4, IL-5, and TGF-ß (Khan & Orenstein, 
2008). Studies have shown an increased production of 
TH2-associated cytokines (IL-41 and IL-5) in PEG (Jaffe et 
al., 1994). The precise trigger for increased tissue eosino-
philia in PEG remains elusive. Recent evidence points to an 
interplay between genetic and environmental factors. For 
example, a positive family history is present in up to 10% of 
patients with PEG (Guajardo et al., 2002). Alternatively, the 
observation of a high correlation between PEG and atopy 
and food allergies may indicate an environmental trigger. 
This is further supported by multiple observations that 
PEG can be ameliorated or even reversed with a change 
to an elimination or elemental diet (Khan & Orenstein, 
2008; Méndez-Sánchez, Chávez-Tapia, Vazquez-Elizondo, 
& Uribe, 2007; Zuo & Rothenberg, 2007).
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Chronic diarrhea is a common diagnostic entity faced 
by many primary care physicians. Primary eosinophilic 
gastroenteritis (PEG), a relatively rare but not uncom-
mon cause of chronic nonbloody diarrhea, presents with 
nonspecific symptoms, making clinical consideration and 
diagnosis extremely challenging. In PEG, eosinophils 
selectively target the gastrointestinal tract, where they 
degranulate, causing inflammation and irritation. We 
report the case of a 46-year-old female with recurrent 
hospitalizations for nausea, vomiting, and diarrhea over 
a nine-month period. After an extensive workup ruling 
out secondary causes of eosinophilia, she was diagnosed 
with PEG. 
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Presentation
PEG has been dubbed a “great imitator” due to its variable 
and nonspecific symptoms, making clinical consideration 
and diagnosis extremely challenging. Common symptoms 
include abdominal pain (most common, in up to 75% of 
patients), nausea, vomiting, diarrhea, and anorexia (Méndez-
Sánchez et al., 2007; Talley, Shorter, Phillips, & Zinsmeister, 
1990). Some have reported PEG presenting similar to intus-
susceptions (Huang, Ko, Huang, & Lee, 2001), pyloric ste-
nosis (Khan & Orenstein, 2000), appendicitis (Tran, Salloum, 
Tshibaka, & Moser, 2000), pancreatitis (Le Connie & Nguyen, 
2004), and ascites (Khalil & Granieri, 2003).  
Level of eosinophilic infiltration is strongly associated with 
presenting symptoms. Mucosal predominant pathology 
commonly presents with a protein-losing enteropathy, 
malabsorption, nausea, vomiting, and diarrhea (Mason & 
Andablo, 2003). Alternatively, muscularis-predominant 
infiltration presents with intestinal obstruction (Khan and 
Orenstein, 2008), while serosal-predominant infiltration 
presents with ascites (Khalil & Granieri, 2003). Mucosal 
involvement is most common (up to 100%), with serosal 
involvement least common (up to 40%); however, these 
findings may be due to the ease of obtaining mucosal tis-
sue on routine endoscopic biopsy as compared to serosal 
tissue, which necessitates a full thickness biopsy (Khan & 
Orenstein, 2008; Talley et al., 1990).
Diagnosis
Diagnosis of PEG is based on gastrointestinal symptoms, 
exclusion of any known causes of eosinophilia in the DT 
(e.g., neoplasm, drug interactions, parasitic infection), and 
a positive biopsy sample. Peripheral eosinophilia is com-
monly absent (>50% of the time [Sleisenger & Fordtran, 
1993]), and not necessary in the diagnosis of PEG. 
Furthermore, degree of peripheral eosinophilia, if pres-
ent, has not been correlated with severity of eosinophilic 
infiltration in the intestinal system (Huang et al., 2001). The 
sensitivity of endoscopic biopsies may be low due to the 
variety of permeating patterns (patchy vs. continuous) and 
layers of infiltration (Simon, Wardlaw, & Rothenberg, 2010). 
Endoscopically, macroscopic signs of mucosal inflamma-
tion are uncommon, but may include ulcerations and fria-
bility. Microscopically, histopathologic evidence consists of 
analysis of eosinophil density, degranulation, and absence 
of other disease features. Diagnosis of muscular or sero-
sal involvement requires an open biopsy via laparotomy or 
laparoscopy. 
Treatment
To date, there are no random controlled trials or definitive 
treatments for PEG. Diet modification to an allergen-free 
or gluten-free diet has been reported as helpful in amelio-
rating or even reversing symptoms as well as reducing the 
need for medical therapy (Méndez-Sánchez et al., 2007). 
Glucocorticoids have been the standard medication for 
management of those who fail diet alteration. Acceptable 
responses have been reported using prednisone (20–40 
mg) for four to eight weeks (Khan & Orenstein, 2008; Vara-
Thorbeck, Toscano-Mendez, & Osorio, 1997). Overall, 
experience has demonstrated varying responses from com-
plete remission to a chronically relapsing pattern (Khan & 
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Figure 1 | Eosinophil Levels and Intestinal Biopsy. (A) Absolute eosinophil levels on two previous hospitalizations and current admission 
(third hospitalization), as well as at one month post current admission. (B) Photomicrograph of small intestine biopsy showing increased 
eosinophils (arrows) and chronic inflammatory cells in the lamina propria with villous architecture preservation and no intraepithelial inflam-
mation (making celiac disease, autoimmune mediated injury, or infections unlikely). 
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Orenstein, 2008; Lee et al., 1993). Therefore, due to the 
side effects of long-term steroid therapy, many attempts 
have been made to find more-targeted immunotherapy. 
For example, small trials have demonstrated successful 
outcomes using immunomodulators such as Montelukast, 
Suplatast, and Omalizumab (Foroughi et al., 2007; Quack 
et al., 2005; Shirai et al., 2001; Stein et al., 2006).
CONCLUSION
PEG is a rare but not uncommon disease that should be 
considered in the differential diagnosis for chronic relaps-
ing nonenterohemorrhagic diarrhea. This case highlights 
the need for a heightened degree of clinical suspicion to 
diagnose PEG due to its varied presentations, and often 
normal laboratory values without peripheral eosinophilia. 
While our patient improved without medical therapy, a 
definitive diagnosis explained her chronic debilitating 
symptoms. This led to relief for both the patient and the 
physician, and allowed for close follow-up with a known 
focus. Increasing physicians’ awareness of PEG may help 
those suffering from its debilitating symptoms.
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